Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Events

Genomics Day 2005: Genomics Day 2005: Public Health Genomics at CDC

Main Page | Agenda | All Abstracts

Group 1: Genetics and Immunity


The impact of Fc receptor IIa for IgG (FcyIIa) polymorphism on malaria and HIV susceptibility in western Kenya
Brouwer KC1, Lal RB1, Mirel LB1, Yang C1, Van Eijk A2, Ayisi J2, Otieno J3, Nahlen BL4, Steketee R1, Lal A1, and Shi YP1.
(1) NCID, CDC
(2) Center for Vector Biology and Control Research, Kenya Medical Research Institute, Kisumu, Kenya
(3) New Nyanza Provincial General Hospital, Ministry of Health, Kisumu, Kenya,
(4) Roll Back Malaria Program, World Health Organization, Geneva, Switzerland

Poster: The impact of Fc receptor IIa for IgG (FcyIIa) polymorphism on malaria and HIV susceptibility in western KenyaGenetic polymorphism of the Fc?IIa receptor on leukocytes determines IgG subclass binding. The histidine-131 variant leads to a receptor with high affinity for human IgG2, whereas the arginine allelic variant binds to IgG1 and IgG3 but poorly to IgG2. Considerable differences in the distribution of the Fc?RIIa polymorphism among ethnic groups have been reported, and this polymorphism has been found to play an important role in autoimmune diseases, especially SLE and infections due to encapsulated bacteria. The current study was undertaken 1) to examine the relationship between Fc?RIIa polymorphism and placental malaria (PM) infection in pregnant women of known HIV-1 serostatus, and 2) to evaluate the effect of polymorphism of the Fc?RIIa on perinatal HIV-1 transmission and HIV-positive child all-cause mortality. Fc?RIIa genotype was determined in 903 mothers and 448 pairs of HIV-seropositive mothers and their infants from a cohort study designed to assess the effect of placental malaria on HIV vertical transmission conducted from 1996 to 2001 in western Kenya . Fc?RIIa polymorphism was analyzed for associations with susceptibility to PM, perinatal HIV infection, all-cause child mortality in HIV-positive children. This study suggests that the IgG2-binding Fc?RIIa-His/His131 genotype is associated with enhanced susceptibility to PM infection in HIV-positive women but not in HIV-negative women. This study also provides the first evidence that the infant Fc?RIIa-His/His131 genotype is associated with susceptibility to perinatal HIV-1 transmission. There is no evidence for an association between HIV-positive child all-cause mortality and Fc?RIIa genotype.

References:

  1. K.C. Brouwer , Renu B. Lal , Lisa B. Mirel , Chunfu Yang , Anne M. Van Eijk , John Ayisi , Juliana Otieno , Bernard L. Nahlen, Richard Steketee , Altaf A. Lal , Shi Y.P. Fc ( receptor IIa (CD32) polymorphism is associated with perinatal transmission of HIV-1 in western Kenya . AIDS 2004, 18: 1187-1194.
  2. K.C. Brouwer, A.A. Lal, Lisa B. Mirel , Renu B. Lal, Anne M. Van Eijk , John Ayisi ,J.Otieno, R.Steketee, B.L. Nahlen, Shi Y.P. Association between genetic polymorphism in Fc receptor IIa for IgG (Fc ( RIIa) and placental malaria in western Kenya . JID 2004, 196: 1192-8

 

 

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd.
    Atlanta, GA 30333 USA
    800-CDC-INFO (800-232-4636)
  • Additional information for Public Health Genomics is available on our contact page.
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #